Astragalus injection as an adjuvant treatment for colorectal cancer: a meta-analysis
Journal Title: Traditional Medicine Research - Year 2020, Vol 5, Issue 1
Abstract
Background: The combination of Chinese patent medicine Astragalus injection and Western medicine has achieved a certain clinical effect in colorectal cancer patients. However, due to the uneven basic conditions and research indicators of these clinical trials, it is difficult to comprehensively evaluate the effect of Astragalus injection in the adjuvant treatment of colorectal cancer. This study aimed to systematically evaluate the efficacy and safety of Astragalus injection as an adjuvant treatment for colorectal cancer. Methods: The Cochrane Library, VIP database, Wanfang database, and Chinese Academic Journal Full Text database were searched for potentially eligible articles from inception to December 15, 2018. Randomized controlled trials in which patients were diagnosed with colorectal cancer were included. Patients in the control group received chemotherapy alone or combined with other drugs, or chemotherapy combined with radiotherapy. Patients in the experimental group were treated with Astragalus injection combined with interventions in the control group. Results: A total of 8 articles were included. Compared with Western medicine alone, the Astragalus injection could improve the therapeutic effect (RR = 1.18, 95% CI (1.01, 1.38), P = 0.03), improved the quality of life of colorectal cancer patients (SMD = 1.18, 95% CI (0.86, 1.50), P <0.001), inhibited leukopenia (RR = 0.55, 95% CI (0.42, 0.71), P < 0.001), reduced neurotoxicity (RR = 0.43, 95% CI (0.34, 0.56), P < 0.001), and reduced the incidence of nausea and vomiting (RR = 0.67, 95% CI (0.55, 0.80), P < 0.001). Conclusion: Astragalus injection can reduce the toxicity and improve the efficiency of the conventional Western medicine in the treatment of colorectal cancer.
Authors and Affiliations
Jia Wang, Zhu Yang, Fengxi Long, Li Luo, Jinlin Wu, Ting Yu, Dongxin Tang
Keywords
Related Articles
- EP ID EP675812
- DOI 10.12032/TMR20191228151
- Views 256
- Downloads 0
The neuroprotective role of Panax notoginseng saponins in APP/PS1 transgenic mice through the modulation of cerebrovascular
Background: Panax notoginseng saponins (PNS) is extracted from Sanqi (Panax notoginseng), which is a valuable herb and has been widely used in traditional Chinese medicine for the treatment of cerebrovascular diseases an...
Application of monoclonal antibody against ginsenoside in ginseng research: a review
Panax genus belonging to a family of Araliaceae grow in Asia (9 species) and in North America (2 species). Especially Panax ginseng was listed in Chinese medical book, Shennong's Classic of Materia Medica approximately 2...
Tu Youyou：A scientist moving forward in controversy
The 13th National People's Congress Standing Committee was held in Beijing on Sept. 17, 2019. President of China Xi Jinping signed a presidential decree to award individuals, national medals and honorary titles. Tu Youyo...
Assessing acupuncture effect in the real world study
Acupuncture, with its unique set of theories and its evident results in clinical practice is an important part of traditional Chinese medicine (TCM), and gaining recognition worldwide for the past few years. Although acu...
Brucea javanica oil inhibits proliferation of hepatocellular carcinoma cells and induces apoptosis via the PI3K/AKT pathway
Background: Brucea javanica oil (BJO), distributed primarily in Southeast Asia, has long been utilized as a therapeutic agent for treating malignancies. However, its anticancer mechanisms are not clearly understood. The...